Table 3.
Stem cell | Advantages | Disadvantages | References |
---|---|---|---|
Embryonic stem cells (ESCs) | (i) Have been shown to improve muscle function in vivo (ii) Pluripotent |
(i) Research limited by regulations (ii) Need presence of box genes (Pax-7) |
|
Induced pluripotent stem cells (IPSCs) | (i) Less regulations (ii) Pluripotent |
(i) More study needed to ensure that there is no tumorigenic potential | |
Satellite cells | (i) Express Pax-7 (ii) Self-proliferating |
(i) Difficult to isolate (ii) Damaged by in vitro culture |
|
Muscle derived stem cells (MDSCs) | (i) Osteogenic and adipogenic | [81, 117] | |
MSCs | (i) High ability to differentiate (ii) Modulate inflammation |
(i) Need more research before in vivo studies | |
Muscle derived CD133+ stem cells | (i) Formed myosin heavy chain (characteristic of craniofacial muscle) (ii) Safe and feasible |
(i) Myogenesis in vitro requires additional cell cultures | |
Mesoangioblasts | (i) Angiogenic (ii) Easy expansion in vitro |
(i) Require factors to improve migration |